[go: up one dir, main page]

HN2000000076A - Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas. - Google Patents

Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas.

Info

Publication number
HN2000000076A
HN2000000076A HN2000000076A HN2000000076A HN2000000076A HN 2000000076 A HN2000000076 A HN 2000000076A HN 2000000076 A HN2000000076 A HN 2000000076A HN 2000000076 A HN2000000076 A HN 2000000076A HN 2000000076 A HN2000000076 A HN 2000000076A
Authority
HN
Honduras
Prior art keywords
citrate
azobiciclo
polymorphes
oct
lamin
Prior art date
Application number
HN2000000076A
Other languages
English (en)
Inventor
Wint Massett Quallich Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN2000000076A publication Critical patent/HN2000000076A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A CIERTOS POLIMORFOS Y FORMA DE CITRATO DE (2-BENZHIDRIL-1-AZOBICICLO (2,2,2.) OCT-311)-(5-ISOPROPIL-METOXIBENCIL) AMINA (EN ADELANTE SAL CITRATO) CRISTALINO Y A SUS COMPOCIONES FARMACEUTICAS.
HN2000000076A 1999-06-01 2000-05-17 Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas. HN2000000076A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699599P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
HN2000000076A true HN2000000076A (es) 2001-02-02

Family

ID=22475353

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000076A HN2000000076A (es) 1999-06-01 2000-05-17 Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas.

Country Status (38)

Country Link
US (1) US6387925B1 (es)
EP (1) EP1181289A1 (es)
JP (1) JP2003501353A (es)
KR (1) KR20020005055A (es)
CN (1) CN1353712A (es)
AP (1) AP2001002350A0 (es)
AR (1) AR029753A1 (es)
AU (1) AU767331B2 (es)
BG (1) BG106139A (es)
BR (1) BR0011125A (es)
CA (1) CA2372236A1 (es)
CO (1) CO5170468A1 (es)
CR (1) CR6513A (es)
CZ (1) CZ20014270A3 (es)
DZ (1) DZ3051A1 (es)
EA (1) EA004206B1 (es)
EE (1) EE200100655A (es)
GT (1) GT200000086A (es)
HK (1) HK1046407A1 (es)
HN (1) HN2000000076A (es)
HR (1) HRP20010884A2 (es)
HU (1) HUP0201798A3 (es)
IL (1) IL145952A0 (es)
IS (1) IS6129A (es)
MX (1) MXPA01012328A (es)
NO (1) NO20015845L (es)
NZ (1) NZ514762A (es)
OA (1) OA11955A (es)
PA (1) PA8496001A1 (es)
PE (1) PE20010155A1 (es)
PL (1) PL352715A1 (es)
SK (1) SK17342001A3 (es)
SV (1) SV2002000092A (es)
TN (1) TNSN00119A1 (es)
TR (1) TR200103472T2 (es)
UY (1) UY26177A1 (es)
WO (1) WO2000073303A1 (es)
ZA (1) ZA200109839B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551846A1 (en) * 2002-10-04 2005-07-13 Merck Sharp & Dohme Ltd. Azabicyclic spiroether derivatives as receptor antagonists
EP1790635A3 (en) * 2003-06-18 2007-06-13 Teva Pharmaceutical Industries, Inc. Processes for preparing amorphous fluvastatin sodium
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
DK0587723T3 (da) * 1991-05-31 1996-04-01 Pfizer Quinuclidinderivater
JP2668164B2 (ja) * 1992-11-12 1997-10-27 ファイザー・インク． Ｐ物質拮抗薬としてのキヌクリジン誘導体
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US6262067B1 (en) * 1999-06-22 2001-07-17 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions

Also Published As

Publication number Publication date
AR029753A1 (es) 2003-07-16
DZ3051A1 (fr) 2004-03-27
PA8496001A1 (es) 2002-07-30
PE20010155A1 (es) 2001-02-08
HUP0201798A3 (en) 2002-10-28
EE200100655A (et) 2003-02-17
NO20015845D0 (no) 2001-11-30
HK1046407A1 (zh) 2003-01-10
UY26177A1 (es) 2000-12-29
TNSN00119A1 (fr) 2005-11-10
NZ514762A (en) 2002-12-20
MXPA01012328A (es) 2002-07-30
NO20015845L (no) 2002-01-30
CZ20014270A3 (cs) 2002-08-14
OA11955A (en) 2006-04-13
JP2003501353A (ja) 2003-01-14
KR20020005055A (ko) 2002-01-16
AP2001002350A0 (en) 2001-12-31
PL352715A1 (en) 2003-09-08
SK17342001A3 (sk) 2002-10-08
GT200000086A (es) 2001-11-21
ZA200109839B (en) 2003-01-29
IS6129A (is) 2001-10-26
HUP0201798A2 (en) 2002-09-28
HRP20010884A2 (en) 2003-04-30
CR6513A (es) 2003-11-25
BG106139A (bg) 2002-05-31
EP1181289A1 (en) 2002-02-27
BR0011125A (pt) 2002-02-19
IL145952A0 (en) 2002-07-25
EA004206B1 (ru) 2004-02-26
AU767331B2 (en) 2003-11-06
WO2000073303A1 (en) 2000-12-07
TR200103472T2 (tr) 2002-05-21
US6387925B1 (en) 2002-05-14
EA200100982A1 (ru) 2002-06-27
CO5170468A1 (es) 2002-06-27
CN1353712A (zh) 2002-06-12
SV2002000092A (es) 2002-02-05
AU4424600A (en) 2000-12-18
CA2372236A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
HN1999000066A (es) Formulaciones farmaceuticas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN2001000139A (es) Interleuquina 2 estabilizada
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
ECSP034850A (es) Sal citrato de 5, 8, 14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
HN1999000089A (es) Formulaciones de ziprasidona
BR0216099B1 (pt) "conjunto de desgaste".
DK1109812T3 (da) Pyrrolobenzodiazepiner
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998003689A (es) Azetidinas
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
BR0307339A (pt) Metabolitos de ácido (3-{[(4-terc-butil-benzil)-(piridina-3-sulfonil)-amino]-m etil}-fenóxi)-acético
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
HN1998000045A (es) Composiciones farmaceuticas
HN2000000076A (es) Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas.
BRPI0408446A (pt) tablete de limpeza
GT200100218A (es) Compuesto agroquimico.
BR0114065A (pt) Triazolo-epotilonas
BR0009469A (pt) Tablete perfumado de detergente
DE602005018646D1 (de) Massageseifenstück
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.
HN1998000056A (es) Agente farmaceutico